{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:31:21Z","timestamp":1781303481546,"version":"3.54.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.autrev.2016.03.009","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T07:17:18Z","timestamp":1457507838000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["\u201cKill\u201d the messenger: Targeting of cell-derived microparticles in lupus nephritis"],"prefix":"10.1016","volume":"15","author":[{"given":"Christoffer T.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas S.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels H.H.","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0005","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01451282","article-title":"A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets","volume":"17","author":"Jacobsen","year":"1998","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.009_bb0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.03.009_bb0015","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","author":"Hanly","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/acr.20116","article-title":"Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis","volume":"62","author":"Faurschou","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01451283","article-title":"A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value","volume":"17","author":"Jacobsen","year":"1998","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.009_bb0030","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"10.1016\/j.autrev.2016.03.009_bb0035","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.009_bb0040","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.009_bb0055","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1002\/art.34624","article-title":"Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions","volume":"64","author":"Wofsy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"20","key":"10.1016\/j.autrev.2016.03.009_bb0060","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.009_bb0065","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1136\/ard.2010.131995","article-title":"Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0070","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar2764","article-title":"Predictors of major infections in systemic lupus erythematosus","volume":"11","author":"Ruiz-Irastorza","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.009_bb0080","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0085","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","article-title":"Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells","volume":"168","author":"Kalaaji","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.12417","article-title":"The effect of cell death in the initiation of lupus nephritis","volume":"179","author":"Fenton","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.009_bb0100","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/art.23626","article-title":"Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus","volume":"58","author":"van Bavel","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.009_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/08916934.2010.541170","article-title":"Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens","volume":"44","author":"Mjelle","year":"2011","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.009_bb0110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0961203309106175","article-title":"Renal cell apoptosis in human lupus nephritis: a histological study","volume":"18","author":"Faurschou","year":"2009","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0115","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/art.34377","article-title":"Microparticles as autoantigens: making immune complexes big","volume":"64","author":"Pisetsky","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.009_bb0120","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0961203310371161","article-title":"The interferon-alpha signature of systemic lupus erythematosus","volume":"19","author":"Obermoser","year":"2010","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.009_bb0125","first-page":"B4548","article-title":"Circulating microparticles in systemic lupus erythematosus","volume":"59","author":"Nielsen","year":"2012","journal-title":"Dan Med J"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrrheum.2010.66","article-title":"Microparticles as autoadjuvants in the pathogenesis of SLE","volume":"6","author":"Pisetsky","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.009_bb0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Munoz","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00281-013-0376-6","article-title":"Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity","volume":"35","author":"Radic","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clim.2004.02.017","article-title":"Apoptosis, subcellular particles, and autoimmunity","volume":"112","author":"Cline","year":"2004","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.009_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/BOR.0000000000000083","article-title":"Beyond apoptosis in lupus","volume":"26","author":"Colonna","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/9544","article-title":"Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity","volume":"5","author":"Bickerstaff","year":"1999","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.009_bb0165","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H","article-title":"Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus","volume":"41","author":"Herrmann","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.009_bb0170","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nri2214","article-title":"Engulfment of apoptotic cells: signals for a good meal","volume":"7","author":"Ravichandran","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.cdd.4402239","article-title":"Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis","volume":"15","author":"Schiller","year":"2008","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0180","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.24535","article-title":"Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus","volume":"60","author":"Munoz","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.cdd.4400460","article-title":"Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease","volume":"6","author":"Rosen","year":"1999","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.009_bb0190","first-page":"343","article-title":"Post-translational modifications, subcellular relocation and release in apoptotic microparticles: apoptosis turns nuclear proteins into autoantigens","volume":"47","author":"Dieker","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.009_bb0195","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1084\/jem.185.5.843","article-title":"Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus","volume":"185","author":"Utz","year":"1997","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0200","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.009_bb0205","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10495-010-0478-8","article-title":"Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players","volume":"15","author":"Kruse","year":"2010","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.009_bb0210","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.4049\/jimmunol.172.11.6692","article-title":"Nucleosomes are exposed at the cell surface in apoptosis","volume":"172","author":"Radic","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cei.12342","article-title":"Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity","volume":"179","author":"Zirngibl","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"Pt 17","key":"10.1016\/j.autrev.2016.03.009_bb0220","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1242\/jcs.02529","article-title":"Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells","volume":"118","author":"Lane","year":"2005","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0225","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1074\/jbc.M111.273144","article-title":"Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles","volume":"287","author":"Bilyy","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clim.2014.05.007","article-title":"The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells","volume":"154","author":"Ullal","year":"2014","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/0891693042000196219","article-title":"Murine lupus autoantibodies identify distinct subsets of apoptotic bodies","volume":"37","author":"Cline","year":"2004","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0240","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.188.2.387","article-title":"Systemic exposure to irradiated apoptotic cells induces autoantibody production","volume":"188","author":"Mevorach","year":"1998","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/35070009","article-title":"Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I","volume":"3","author":"Coleman","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"21","key":"10.1016\/j.autrev.2016.03.009_bb0250","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1128\/JVI.05406-11","article-title":"H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans","volume":"85","author":"Khurana","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0255","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar3707","article-title":"Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies","volume":"14","author":"Liu","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.12359","article-title":"Acetylated histones contribute to the immunostimulatory potential of eutrophil extracellular traps in systemic lupus erythematosus","volume":"179","author":"Pieterse","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"73","key":"10.1016\/j.autrev.2016.03.009_bb0265","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci Transl Med"},{"issue":"21","key":"10.1016\/j.autrev.2016.03.009_bb0270","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.03.009_bb0275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13075-015-0726-y","article-title":"A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources","volume":"17","author":"Leffler","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.009_bb0280","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol"},{"issue":"73","key":"10.1016\/j.autrev.2016.03.009_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"issue":"157","key":"10.1016\/j.autrev.2016.03.009_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004801","article-title":"NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus","volume":"4","author":"Campbell","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2016.03.009_bb0295","article-title":"Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice","author":"Knight","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.009_bb0300","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","author":"Lood","year":"2016","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.009_bb0305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2006.09.001","article-title":"Circulating microparticles: pathophysiology and clinical implications","volume":"21","author":"Piccin","year":"2007","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.009_bb0310","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1160\/TH10-09-0595","article-title":"Pre-analytical and analytical issues in the analysis of blood microparticles","volume":"105","author":"Yuana","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2016.03.009_bb0315","article-title":"Detection and isolation of cell-derived microparticles are compromised by protein complexes due to shared biophysical parameters","author":"Gyorgy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2016.03.009_bb0320","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Yanez-Mo","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0325","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.34381","article-title":"Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation","volume":"64","author":"Nielsen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.009_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2011.02.001","article-title":"Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus","author":"Ullal","year":"2011","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.009_bb0335","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/art.38065","article-title":"Unique protein signature of circulating microparticles in systemic lupus erythematosus","volume":"65","author":"Ostergaard","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.009_bb0340","doi-asserted-by":"crossref","DOI":"10.1177\/0961203315580146","article-title":"Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis","author":"Nielsen","year":"2015","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0345","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cyto.a.20510","article-title":"Human galectins as sensors for apoptosis\/necrosis-associated surface changes of granulocytes and lymphocytes","volume":"73","author":"Beer","year":"2008","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0350","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/emmm.201201846","article-title":"The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes","volume":"5","author":"Cloutier","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"5965","key":"10.1016\/j.autrev.2016.03.009_bb0355","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1181928","article-title":"Platelets amplify inflammation in arthritis via Collagen-dependent microparticle production","volume":"327","author":"Boilard","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.009_bb0360","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2006.061309","article-title":"Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals","volume":"66","author":"Biro","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0365","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","article-title":"Direct binding of C1q to apoptotic cells and cell blebs induces complement activation","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0370","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4049\/jimmunol.1100631","article-title":"Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles","volume":"189","author":"Schiller","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.03.009_bb0375","article-title":"Circulating apoptotic microparticles in SLE patients drive the activation of DC subsets and prime neutrophils for NETosis","author":"Dieker","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.009_bb0380","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1529-0131(199804)41:4<613::AID-ART8>3.0.CO;2-A","article-title":"Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes","volume":"41","author":"Nielsen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.009_bb0385","first-page":"17","article-title":"Clearing the complexity: immune complexes and their treatment in lupus nephritis","volume":"4","author":"Toong","year":"2011","journal-title":"Int J Nephrol Renov Dis"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.009_bb0390","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.humimm.2013.04.030","article-title":"Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients","volume":"74","author":"Nisihara","year":"2013","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.009_bb0395","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/08916934.2013.764992","article-title":"C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis","volume":"46","author":"Sjowall","year":"2013","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.009_bb0400","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/6669","article-title":"Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily","volume":"6","author":"Hohenester","year":"1999","journal-title":"Nat Struct Biol"},{"issue":"19","key":"10.1016\/j.autrev.2016.03.009_bb0405","first-page":"4530","article-title":"Interactions between galectin-3 and Mac-2-binding protein mediate cell\u2013cell adhesion","volume":"56","author":"Inohara","year":"1996","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.009_bb0410","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0415","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000026","article-title":"Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus","volume":"1","author":"Nielsen","year":"2014","journal-title":"Lupus Sci Med"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.009_bb0420","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/emboj\/17.6.1606","article-title":"Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin","volume":"17","author":"Sasaki","year":"1998","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0425","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0961203308094361","article-title":"Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis","volume":"18","author":"Kang","year":"2009","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0430","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2353\/ajpath.2008.070938","article-title":"The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells","volume":"172","author":"Thijssen","year":"2008","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0435","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1022>3.3.CO;2-Q","article-title":"Glycoprotein 90K\/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation","volume":"91","author":"Tinari","year":"2001","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.009_bb0440","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2249.1996.d01-839.x","article-title":"The treatment of systemic lupus erythematosus (SLE) in NZB\/WF1 hybrid mice; studies with recombinant murine DNase and with dexamethasone","volume":"106","author":"Macanovic","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0445","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1191\/096120399678847380","article-title":"Recombinant human Dnase I (rhDNase) in patients with lupus nephritis","volume":"8","author":"Davis","year":"1999","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.009_bb0450","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2015.08.010","article-title":"Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review","volume":"15","author":"Kronbichler","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.009_bb0455","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1310050","article-title":"Necroptosis","volume":"370","author":"Linkermann","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:07:37Z","timestamp":1718402857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721630057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S156899721630057X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cKill\u201d the messenger: Targeting of cell-derived microparticles in lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}